Hubei Biocause Pharmaceutical (000627.SZ) subsidiary CHINA BEST life insurance company's accumulated premium income from January to August reached approximately 29.03 billion yuan.

15:59 17/09/2024

Tianmao Group (000627.SZ) has announced that its subsidiary, Guohua Life Insurance Co., Ltd., a company controlled by the company, will follow according to...

Hubei Biocause Pharmaceutical (000627.SZ) announces that its controlling subsidiary, CHINA BEST Life Insurance Co., Ltd., is proceeding with business development in accordance with the overall strategy of "firmly transitioning for development, highlighting value growth, comprehensively improving capabilities, and moving towards a mature insurance enterprise". The company is focusing on value-based business, continuously promoting business structure optimization. From January 1, 2024 to August 31, 2024, the accumulated original insurance premium income is approximately 29.03 billion yuan.

Hunan Silver (002716.SZ) director Rongqi resigns

Jiangsu Linyang Energy (601222.SH) holding shareholder Huahong Electronics plans to increase its holdings by 50-100 million yuan.

China National Nuclear Power (601985.SH): Jiangsu Lianyungang Port plans to sell 4% equity stake in China Nuclear Su Energy, while the company's ownership in China Nuclear Su Energy remains unchanged.

Hunan Silver (002716.SZ) director Rongqi resigns

Jiangsu Linyang Energy (601222.SH) holding shareholder Huahong Electronics plans to increase its holdings by 50-100 million yuan.